Image

Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

Testing NMD670 for adults with Type 3 Spinal Muscular Atrophy.

Recruiting
18-75 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study aims to test a medicine called NMD670 for people with **Type 3 Spinal Muscular Atrophy (SMA)**. SMA is a disease that makes muscles weak. Type 3 means patients can walk but might have trouble doing so over long distances. We will check if NMD670 is safe and helps these patients.

Eligibility: We are looking for adults who can walk at least 50 meters without help, have a body mass index (BMI) between 19-35, and have a genetic confirmation of SMA. You must not have other diseases that affect muscles, nor have had certain surgeries.

  • **Study Length**: Lasts several months, with regular check-ups.
  • **Visits Required**: You will need to visit the clinic multiple times.
  • **Compensation**: You may receive compensation for your time and travel.

Participants must agree to use birth control and be willing to sign a consent form. If interested, ensure you haven't used other experimental treatments recently. This study helps us learn if NMD670 can be a new treatment for SMA Type 3.

Print
Study details
    Spinal Muscular Atrophy

NCT05794139

NMD Pharma A/S

31 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.